Lovastatin and Resveratrol Synergistically Improve Wound Healing and Inhibit Bacterial Growth
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020851 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Norah A AlJunaydil und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: Resveratrol, Lovastatin, Wound Healing, Anti-Bacterial Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Dentistry Research Center and the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia.
Themen: Wundversorgung
Abstract (Originalsprache)
Wound healing is a complex physiological process, with scarring and infection caused by Staphylococcus aureus and Pseudomonas aeruginosa being the most common complications. The reutilization of known medications has received increased attention for their role in cell function as small molecules. Examples of these include lovastatin, a cholesterol-lowering agent, and resveratrol, which have multiple biological properties. Both molecules have been reported to improve wound healing and possess antibacterial properties, with conflicting results. The wound-healing capabilities of human mesenchymal stem cells were evaluated after exposure to lovastatin, resveratrol, and their combination through scratch test, migrations assay, and qPCR. Protein docking was performed to assess the lovastatin/resveratrol combination as potential wound-healing targets. AlamarBlue assay was used to determine cell viability. Additionally, the impact of lovastatin and resveratrol combination to inhibit the growth of S. aureus and P. aeruginosa was tested using broth microdilution test and checkerboard assay to determine synergism. The combination of lovastatin 0.1 μM and resveratrol 0.1 μM synergistically improved wound healing and demonstrated an additive effect against S. aureus and P. aeruginosa, presenting potential antibacterial applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh 11451, Saudi Arabia.
- Molecular and Cell Biology Laboratory, Prince Naif bin Abdulaziz Health Research Center, College of Dentistry, King Saud University Medical City, King Saud University, Riyadh 11545, Saudi Arabia.
- Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, King Saud University, Riyadh 11545, Saudi Arabia.
ORCID-Profile: Norah A AlJunaydil, Rhodanne Nicole A Lambarte, Terrence S Sumague, Abdurahman A Niazy
Förderung
- College of Dentistry Research Center and the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia
Zitieren
APA
AlJunaydil, N. A., Lambarte, R. N. A., Sumague, T. S., Alghamdi, O. G., & Niazy, A. A. (2025). Lovastatin and Resveratrol Synergistically Improve Wound Healing and Inhibit Bacterial Growth. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020851
Vancouver
AlJunaydil NA, Lambarte RNA, Sumague TS, Alghamdi OG, Niazy AA. Lovastatin and Resveratrol Synergistically Improve Wound Healing and Inhibit Bacterial Growth. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020851
BibTeX
@article{AlJunaydil2025,
author = {AlJunaydil, Norah A and Lambarte, Rhodanne Nicole A and Sumague, Terrence S and Alghamdi, Osama G and Niazy, Abdurahman A},
title = {Lovastatin and Resveratrol Synergistically Improve Wound Healing and Inhibit Bacterial Growth},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020851}
}
EUVIMED